CorMedix Statistics Share Statistics CorMedix has 74.65M
shares outstanding. The number of shares has increased by 21.42%
in one year.
Shares Outstanding 74.65M Shares Change (YoY) 21.42% Shares Change (QoQ) 11.78% Owned by Institutions (%) 36.38% Shares Floating 66.63M Failed to Deliver (FTD) Shares 2,409 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 14.18M, so 18.99% of the outstanding
shares have been sold short.
Short Interest 14.18M Short % of Shares Out 18.99% Short % of Float 19.19% Short Ratio (days to cover) 3.55
Valuation Ratios The PE ratio is -26.6 and the forward
PE ratio is 6.12.
CorMedix's PEG ratio is
0.4.
PE Ratio -26.6 Forward PE 6.12 PS Ratio 10.97 Forward PS 2.5 PB Ratio 5.63 P/FCF Ratio -9.4 PEG Ratio 0.4
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CorMedix.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.39,
with a Debt / Equity ratio of 0.01.
Current Ratio 3.39 Quick Ratio 3.16 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.01 Interest Coverage -614.1
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $679.25K Profits Per Employee $-280.16K Employee Count 64 Asset Turnover 0.37 Inventory Turnover 0.42
Taxes Income Tax -1.39M Effective Tax Rate 7.22%
Stock Price Statistics The stock price has increased by 115.28% in the
last 52 weeks. The beta is 1.77, so CorMedix's
price volatility has been higher than the market average.
Beta 1.77 52-Week Price Change 115.28% 50-Day Moving Average 12.22 200-Day Moving Average 10.83 Relative Strength Index (RSI) 44.16 Average Volume (20 Days) 3,144,888
Income Statement In the last 12 months, CorMedix had revenue of 43.47M
and earned -17.93M
in profits. Earnings per share was -0.3.
Revenue 43.47M Gross Profit 40.28M Operating Income -22.36M Net Income -17.93M EBITDA -18.83M EBIT -19.29M Earnings Per Share (EPS) -0.3
Full Income Statement Balance Sheet The company has 40.65M in cash and 517.01K in
debt, giving a net cash position of 40.13M.
Cash & Cash Equivalents 40.65M Total Debt 517.01K Net Cash 40.13M Retained Earnings -339.63M Total Assets 252.6B Working Capital 216.35B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.61M
and capital expenditures -115.73K, giving a free cash flow of -50.73M.
Operating Cash Flow -50.61M Capital Expenditures -115.73K Free Cash Flow -50.73M FCF Per Share -0.86
Full Cash Flow Statement Margins Gross margin is 92.66%, with operating and profit margins of -51.43% and -41.24%.
Gross Margin 92.66% Operating Margin -51.43% Pretax Margin -44.45% Profit Margin -41.24% EBITDA Margin -43.32% EBIT Margin -51.43% FCF Margin -116.7%
Dividends & Yields CRMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CRMD is $17,
which is 37.1% higher than the current price. The consensus rating is "Buy".
Price Target $17 Price Target Difference 37.1% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 26, 2019. It was a
backward
split with a ratio of 1:5.
Last Split Date Mar 26, 2019 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -0.61 Piotroski F-Score 6
